Search research articles
Contact Us
Filters
Showing results (41-50 of 60) with videos related to
Page
of 6
Sort By:
American Journal of Epidemiology
|
November 20, 2023
Postacute symptoms 4 months after SARS-CoV-2 infection during the Omicron period: a nationwide Danish questionnaire study
Lampros Spiliopoulos, Anna Irene Vedel Sørensen, Peter Bager, et al.
The Journal of Allergy and Clinical Immunology
|
October 6, 2009
Trichuris suis ova therapy for allergic rhinitis: a randomized, double-blind, placebo-controlled clinical trial
Peter Bager, John Arnved, Steen Rønborg, et al.
Acta Oncologica (Stockholm, Sweden)
|
November 11, 2014
Common filaggrin gene mutations and risk of cervical cancer
Peter Bager, Jan Wohlfahrt, Erik Sørensen, et al.
Occupational and Environmental Medicine
|
January 28, 2025
Association between biosecurity and zoonotic transmission of LA-MRSA CC398 from industrial pig farms to farm workers and their household members
Peter Bager, Md Zohorul Islam, Tinna Ravnholt Urth, et al.
The Lancet Regional Health. Europe
|
July 6, 2022
Observed protection against SARS-CoV-2 reinfection following a primary infection: A Danish cohort study among unvaccinated using two years of nationwide PCR-test data
Daniela Michlmayr, Christian Holm Hansen, Sophie Madeleine Gubbels, et al.
Scandinavian Journal of Medicine & Science in Sports
|
May 8, 2021
Chronic hyperglycemia, hypercholesterolemia, and metabolic syndrome are associated with risk of tendon injury
Dorthe Skovgaard, Volkert D Siersma, Soren Bering Klausen, et al.
NPJ Vaccines
|
March 4, 2024
A register and questionnaire study of long-term general health symptoms following SARS-CoV-2 vaccination in Denmark
Elisabeth O'Regan, Ingrid Bech Svalgaard, Anna Irene Vedel Sørensen, et al.
The Lancet. Infectious Diseases
|
October 21, 2022
Risk of reinfection, vaccine protection, and severity of infection with the BA.5 omicron subvariant: a nation-wide population-based study in Denmark
Christian Holm Hansen, Nikolaj Ulrik Friis, Peter Bager, et al.
The Lancet. Infectious Diseases
|
June 25, 2021
Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study
Peter Bager, Jan Wohlfahrt, Jannik Fonager, et al.
Emerging Microbes & Infections
|
January 23, 2024
Comparison of morbidity and mortality after bloodstream infection with vancomycin-resistant versus -susceptible <i>Enterococcus faecium: a</i> nationwide cohort study in Denmark, 2010-2019
Peter Bager, Jonas Kähler, Mikael Andersson, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 60) with videos related to
Sort By:
Page
of 6
American Journal of Epidemiology
|
November 20, 2023
Postacute symptoms 4 months after SARS-CoV-2 infection during the Omicron period: a nationwide Danish questionnaire study
Lampros Spiliopoulos, Anna Irene Vedel Sørensen, Peter Bager, et al.
The Journal of Allergy and Clinical Immunology
|
October 6, 2009
Trichuris suis ova therapy for allergic rhinitis: a randomized, double-blind, placebo-controlled clinical trial
Peter Bager, John Arnved, Steen Rønborg, et al.
Acta Oncologica (Stockholm, Sweden)
|
November 11, 2014
Common filaggrin gene mutations and risk of cervical cancer
Peter Bager, Jan Wohlfahrt, Erik Sørensen, et al.
Occupational and Environmental Medicine
|
January 28, 2025
Association between biosecurity and zoonotic transmission of LA-MRSA CC398 from industrial pig farms to farm workers and their household members
Peter Bager, Md Zohorul Islam, Tinna Ravnholt Urth, et al.
The Lancet Regional Health. Europe
|
July 6, 2022
Observed protection against SARS-CoV-2 reinfection following a primary infection: A Danish cohort study among unvaccinated using two years of nationwide PCR-test data
Daniela Michlmayr, Christian Holm Hansen, Sophie Madeleine Gubbels, et al.
Scandinavian Journal of Medicine & Science in Sports
|
May 8, 2021
Chronic hyperglycemia, hypercholesterolemia, and metabolic syndrome are associated with risk of tendon injury
Dorthe Skovgaard, Volkert D Siersma, Soren Bering Klausen, et al.
NPJ Vaccines
|
March 4, 2024
A register and questionnaire study of long-term general health symptoms following SARS-CoV-2 vaccination in Denmark
Elisabeth O'Regan, Ingrid Bech Svalgaard, Anna Irene Vedel Sørensen, et al.
The Lancet. Infectious Diseases
|
October 21, 2022
Risk of reinfection, vaccine protection, and severity of infection with the BA.5 omicron subvariant: a nation-wide population-based study in Denmark
Christian Holm Hansen, Nikolaj Ulrik Friis, Peter Bager, et al.
The Lancet. Infectious Diseases
|
June 25, 2021
Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study
Peter Bager, Jan Wohlfahrt, Jannik Fonager, et al.
Emerging Microbes & Infections
|
January 23, 2024
Comparison of morbidity and mortality after bloodstream infection with vancomycin-resistant versus -susceptible <i>Enterococcus faecium: a</i> nationwide cohort study in Denmark, 2010-2019
Peter Bager, Jonas Kähler, Mikael Andersson, et al.
Page
of 6